Terbigen 250 Tablet
By Terbigen
Rx
7 Tablet in a Strip
Composition
Terbinafine(250mg)
Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.
Expires on or after
April, 2026
When using Terbigen 250 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while taking this medication, so it's vital to consult your doctor for proper guidance. It is not advisable to use Terbigen 250 Tablet if you have severe liver disease or if your liver disease is currently active. Should you experience any signs or symptoms of jaundice while on this medication, notify your doctor immediately.
Terbigen 250 Tablet requires caution in patients with kidney disease. Adjusting the dosage may be necessary. Consult your doctor regarding its use.
When taking Terbigen 250 Tablet, be cautious when drinking alcohol. It is recommended to consult your doctor regarding alcohol consumption along with this medication.
When taking Terbigen 250 Tablet, be cautious while driving as it may cause side effects that can impact your driving abilities.
Terbigen 250 Tablet is believed to be safe for use during pregnancy based on animal studies. Limited human studies are available, but they also suggest minimal risk to the developing baby.
Terbigen 250 Tablet should be avoided during breastfeeding as it may pass into breastmilk and harm the baby. It is better to consult your doctor before using Terbigen 250 Tablet.
Habit Forming | No |
Chemical Class | Allylamine |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Fungal ergosterol synthesis inhibitor |
₹192
Inclusive of all taxes
Content verified by
Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024